Search Within

Department of Medicine

Formats
  1. Journal Article (19593)
  2. Meeting Abstract (16038)
  3. Review (1150)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22321)
  2. Hematologic Malignancies, Division of (13278)
  3. Center for Hematologic Malignancies (11061)
  4. GSK Faculty (10646)
  5. Survivorship Research (9330)
  6. Division of Subspecialty Medicine (7535)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1071)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2111)

More Publishers

Results (39622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trial in progress: Phase 1/2 study of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced solid tumors
    Meeting Abstract

    Schoenfeld, A. J.; Warner, A. B.; Chesney, J. A.; Thomas, S. S.; Moyers, J. T.; In, G. K.; Shoushtari, A. N.; Samhouri, Y.; Hari, P.; Ramsingh, G.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • A phase II parallel arm study of sacituzumab govitecan-hziy in patients with advanced thymoma and thymic carcinoma
    Meeting Abstract

    Marks, J. A.; Agarwal, S.; Ahn, J.; Reuss, J. E.; Altan, M.; Nabel, C.; Gutierrez, M. E.; Garassino, M. C.; Riely, G. J.; Wakelee, H.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Comprehensive pan-cancer analysis of oncogenic MET rearrangements with a focus on targetability in NSCLC
    Meeting Abstract

    Vojnic, M.; Febres-Aldana, C. A.; Odintsov, I.; Zhang, T.; Beach, C. Z.; Lu, D.; Mattar, M. S.; Gazzo, A.; Gili, L.; Harshan, M.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Genomic correlates of response to chemoimmunotherapy in STK11MUT and KEAP1MUT metastatic non-small cell lung cancer
    Meeting Abstract

    Saini, A.; Elkrief, A.; Hong, L.; Ricciuti, B.; Garbo, E.; Pecci, F.; Makarem, M.; Di Federico, A.; Gandhi, M. M.; Aldea, M.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Lurbinectedin synergizes with selinexor by inhibiting DNA damage repair and enhancing immune cell infiltration in neuroendocrine lung tumors
    Meeting Abstract

    Redin, E.; Manoj, P.; Qiu, J.; Zhong, H.; Vural, S.; Zhan, Y.; Koche, R.; Socci, N.; DeStanchina, E.; Rudin, C. M.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy of selpercatinib by RET fusion partner in RET+ NSCLC: Results from the LIBRETTO-001 and LIBRETTO-431 trials
    Meeting Abstract

    Solomon, B.; Drilon, A.; Park, K.; Novello, S.; Nadal, E.; Besse, B.; Peled, N.; Peterson, P.; Barker, S.; Szpurka, A.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • LCMC3: Clinical utility of SUVmax on preoperative 18F-FDG PET-CT in resectable NSCLC treated with neoadjuvant atezolizumab
    Meeting Abstract

    Merritt, R.; Patterson, G. A.; Toloza, E. M.; Lee, J. M.; Raz, D. J.; Baciewicz, F.; Weyant, M.; Molena, D.; Isbell, J.; Kim, J.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Machine learning-based clinicogenomic prediction of response to PD-(L)1 inhibition in KRAS altered non-small cell lung cancer
    Meeting Abstract

    Boiarsky, D.; Hong, L.; Ricciuti, B.; Cooper, A.; Saad, M.; Elkrief, A.; Di Federico, A.; Aminu, M.; Rinsurongkawong, W.; Lewis, J.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Differential CD8+FoxP3+T cell infiltration patterns associate with pathologic response after neoadjuvant anti-PD-1 in NSCLC
    Meeting Abstract

    Fotheringham, M.; Green, B.; Roskes, J. S.; Cohen, E.; Zhang, B.; Engle, L. L.; Wang, D.; Jimenez-Sanchez, D.; Caushi, J. X.; Zhang, J.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • LCMC3: Long-term disease-free and overall survival and their association with ctDNA after neoadjuvant atezolizumab for NSCLC
    Meeting Abstract

    Owen, D. H.; Chaft, J. E.; Haura, E. B.; Toloza, E.; Waqar, S. N.; Patterson, G. A.; Finley, D.; Blasberg, J.; Raz, D.; Salgia, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save